Trial intelligence / Profile preview

Sevoflurane Postconditioning for Cognitive Function in Carotid Surgery

NCT04950205Phase 1Unknown

Sponsor
Second Affiliated Hospital of Zhejiang University School of Medicine
Start
Jun 2021
Primary completion
Dec 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised trial of sevoflurane in Post-operative cognitive dysfunction (POCD) (2 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoints: Mini-Mental State Examination and Montreal Cognitive Assessment. Status: unknown.

02

Drugs

sevoflurane
03

Conditions

Post-operative cognitive dysfunction (POCD)

Beyond the preview

Go deeper on NCT04950205.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04950205.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call